Collaborations & Alliances
Related Searches:
Filter by:
376 - 390 of 1093 results
July 14, 2011
Collaboration will aid in biologic, biosimilar development
Read More »
July 14, 2011
OSDrC delivery tech adds to Catalent's oral solid dosage offerings
Read More »
July 13, 2011
Aslan Pharmaceuticals and Array BioPharma have entered into a license agreement to develop Array’s HER2/EGFR inhibitor, ARRY-543, currently in Phase II development for solid tumors.
Read More »
July 13, 2011
Particle Sciences, Inc. (PSI) and Absorption Systems have formed a partnership to provide clients with enhanced drug development services by integrating preclinical pharmacokinetic data into the dosage form development.
Read More »
July 12, 2011
Mylan's Matrix Laboratories Ltd. entered an expanded licensing agreement with Gilead Sciences for the rights to produce and market generic versions of three Gilead HIV/AIDS therapies, currently in late-stage development.
Read More »
July 12, 2011
Companies collaborate on second candidate for MANF-based therapeutic for the treatment of the beta cell destruction at the root of diabetes.
Read More »
July 11, 2011
Micromet has entered into a collaboration agreement with Amgen for the research of BiTE antibodies against three undisclosed solid tumor targets.
Read More »
July 8, 2011
Onconova Therapeutics and SymBio Pharmaceuticals will collaborate to develop and commercialize rigosertib in Japan and Korea.
Read More »
July 7, 2011
Evotec in three-year discovery collaboration with UCB for CNS disorders
Read More »
July 6, 2011
Biogen Idec has selected Unilabs to provide a companion diagnostic anti-JCV antibody assay test, called STRATIFY-JCV.
Read More »
July 6, 2011
Cambrex Corp. and Tillotts Pharma have entered into a development and commercialization agreement using a new mesalamine-based (5-ASA) technology for an Inflammatory Bowel Disease (IBD) treatment.
Read More »
July 5, 2011
Pact will focus on development, manufacturing
Read More »
July 5, 2011
Diagnostic unit gains second commercial clinical test contract.
Read More »
June 30, 2011
Two-year deal covers development services for two candidates
Read More »
June 29, 2011
Florida Biologix to manufacture anti-cancer agent for early trials
Read More »
376 - 390 of 1093 results
